ING Groep NV Has $11.33 Million Stake in Kenvue Inc. $KVUE

ING Groep NV reduced its position in shares of Kenvue Inc. (NYSE:KVUE) by 21.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 698,091 shares of the company’s stock after selling 193,233 shares during the period. ING Groep NV’s holdings in Kenvue were worth $11,330,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Salomon & Ludwin LLC acquired a new position in Kenvue during the 3rd quarter worth approximately $25,000. NBT Bank N A NY lifted its position in shares of Kenvue by 180.3% in the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after purchasing an additional 1,006 shares in the last quarter. Cornerstone Planning Group LLC boosted its holdings in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after purchasing an additional 1,361 shares during the last quarter. Golden State Wealth Management LLC boosted its holdings in Kenvue by 150.1% during the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares during the last quarter. Finally, Trust Co. of Vermont grew its position in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after purchasing an additional 804 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Buying and Selling

In other Kenvue news, Director Jeffrey C. Smith bought 3,200,000 shares of the firm’s stock in a transaction on Friday, December 12th. The shares were purchased at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the transaction, the director directly owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.68% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on KVUE. Jefferies Financial Group cut shares of Kenvue from a “buy” rating to a “hold” rating and cut their price target for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Evercore set a $18.00 target price on Kenvue in a report on Tuesday, October 28th. Edward Jones downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. Zacks Research raised Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Finally, Barclays increased their price objective on Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Four equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat, Kenvue presently has a consensus rating of “Hold” and a consensus price target of $19.46.

Kenvue Stock Up 1.0%

KVUE opened at $18.50 on Thursday. The stock’s fifty day simple moving average is $17.32 and its 200 day simple moving average is $17.78. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17. The stock has a market cap of $35.44 billion, a PE ratio of 24.67 and a beta of 0.59. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th will be paid a $0.2075 dividend. The ex-dividend date is Wednesday, February 11th. This represents a $0.83 annualized dividend and a dividend yield of 4.5%. Kenvue’s dividend payout ratio is 110.67%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.